European Journal of Obstetrics & Gynecology and Reproductive Biology: X (Sep 2024)
A letter to editor – Critical appraisal on “Determining the cost-effectiveness of follitropin alfa biosimilar compared to follitropin alfa originator in women undergoing fertility treatment in France.”
Abstract
No abstracts available.